Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: Results from a phase III randomized trial

J. Sieper, R. Landewé, M. Rudwaleit, D. Van Der Heijde, M. Dougados, P. J. Mease, J. Braun, A. Deodhar, A. Kivitz, J. Walsh, B. Hoepken, T. Nurminen, W. P. Maksymowych

Research output: Contribution to journalArticle

35 Scopus citations

Fingerprint Dive into the research topics of 'Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: Results from a phase III randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences